The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with The Kinetix Group Participates in The International Liver Congress 2018
Published: Apr 06, 2018
NEW YORK, April 6, 2018 /PRNewswire/ -- The NASH Network (NASHNET), in collaboration with The Kinetix Group is focused on improving NASH care delivery by collaboration on innovation, best practice sharing, and real world research. NASHNET will be participating at the upcoming International Liver Congress, hosted by the European Association for the Study of the Liver (EASL) on April 11th - 15th at Paris Expo Porte de Versailles in Paris, France.
Attended by our NASHNET charter advisors such as Dr. Douglas Dieterich (Mount Sinai), Dr. Norman Sussman (Baylor College of Medicine), and Dr. George Therapondos (Ochsner Health System), we look forward to:
- Facilitating the global expansion of NASHNET
- Collaborating on areas of opportunity to accelerate the adoption of treatment options
- Discussing innovative technology and process initiatives with NASH thought leaders
For more information, please contact Harshini Parvatha at email@example.com
NASH Network (NASHNET): Nonalcoholic Steatohepatitis (NASH) is a challenging high-volume chronic condition that lacks a standardized care delivery model. Our multi-disciplinary team of experts are here to change that. NASHNET is a global Centers of Excellence Network represented by leading healthcare systems committed to NASH care delivery innovation. Our charter members are collaborating to solve for key challenges across the NASH spectrum, including care coordination, population health, real world evidence, and clinical trials. To learn more, go to www.nashnetwork.org.
The Kinetix Group (TKG) empowers life science companies to effectively engage with health system and payer customers by developing strategies and real world solutions aimed at impacting the right patient, at the right time, with the right care. TKG also works directly with health systems and payers to build and implement value-based delivery models for identified patient populations. To learn more, go to www.thekinetixgroup.com.